Menhibrix Approved to Prevent Bacterial Infections in Youngsters

Your Health Matters

FRIDAY, June 15 (HealthDay News) — The combination vaccine Menhibrix has been approved by the U.S. Food and Drug Administration to prevent two deadly bacterial infections among infants and toddlers — Neisseria meningitides serogroups C and Y and Haemophilus influenzae type b.

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave